LinkedIn Learning vs TheRareLens

Achieve your next career goal with LinkedIn Learning—the only skill development platform based on the real-time skill and career insights from LinkedIn. With the LinkedIn Learning app, you can: • Learn from industry experts on the most in-demand business, tech, and creative skills • Get personalized content recommendations based on your skills and goals • Stay up-to-date on the latest skills with new courses added weekly • Learn the way you want online or offline—with bite-sized video, audio, or full course options • Start learning a little bit every day with Daily • Earn Professional Certificates and Continuing Education Credits • Add certificates of completion to your LinkedIn profile • Learn in the language that's best for you, including English, German, French, Spanish, Japanese, Chinese, Portuguese, Dutch, Indonesian, Polish, Turkish, and Korean Trending topics include: • Artificial intelligence and generative AI • Business productivity and software • Cybersecurity • Diversity, equity, and inclusion • Leadership and management • Software development The LinkedIn Learning app is free to download. With a subscription, you can access our full library as well as LinkedIn Premium networking tools. If you choose to subscribe, your subscription will automatically renew and will charge your credit card through iTunes account, unless auto-renew is turned off at least 24-hours before the end of the current period. You can turn off auto-renew at any time from your iTunes account settings. LinkedIn is committed to making its products and features accessible. Please find our statements to support this commitment https://linkedin.com/accessibility/reports. LinkedIn privacy policy: https://linkedin.com/legal/privacy-policy LinkedIn terms of use: https://linkedin.com/legal/user-agreement

RareLens: Research Equity for Rare Diseases The Problem Over 7,000 rare and autoimmune diseases exist but fewer than 5% have an approved treatment. Research funding from the NIH often doesn't reflect how many people a disease affects or how severely it impacts their lives. Patients wait years for a diagnosis. Researchers don't know where the biggest gaps are. Advocates don't have the data to make their case. RareLens changes that. Who It's For — Patients and caregivers who want to understand where their disease stands in the research landscape — Scientists and clinicians looking for high-impact, underserved areas to direct their work — Patient advocates building the case for more funding — Students and researchers exploring rare disease epidemiology and health equity How It Works RareLens pulls live data from NIH Reporter, PubMed, and ClinicalTrials.gov to score every disease across two dimensions: • Research Score: how much NIH funding and published science exists for a disease • Patient Burden Score: how prevalent the disease is and how severely it affects quality of life The difference between the two is the Gap Score a single number that tells you exactly how underfunded a disease is relative to the burden it places on patients. Features — Live gap scores and funding trends for rare and autoimmune diseases — Disease profiles with NIH funding history, active clinical trials, and recent publications — Year-over-year funding change tracker to catch emerging shifts in research investment — Bookmark and track the diseases that matter to you — Search any disease, even one not in our catalog and get a full score within seconds The Science Behind It Every score is formula-based, sourced from public government data, and fully reproducible. RareLens was built on a peer-reviewed methodology grounded in NIH Reporter, Orphanet prevalence data, and the Global Burden of Disease Study 2021. This is not a curated list. This is a live, data-driven map of where science is and isn't showing up for patients.